Back to top
more

Zimmer Biomet (ZBH)

(Delayed Data from NYSE)

$108.18 USD

108.18
1,175,736

-0.51 (-0.47%)

Updated Nov 8, 2024 04:00 PM ET

After-Market: $108.25 +0.07 (0.06%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value F Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (74 out of 250)

Industry: Medical - Products

Zacks News

New Strong Sell Stocks for November 20th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

    Zimmer Biomet (ZBH) Misses Q3 Earnings, Meets Sales Estimate

    Zimmer Biomet (ZBH) posts in line revenues on the back of soft Knees and Hips segments in Q3.

      Tracey Ryniec headshot

      5 Earnings All-Stars to Start the Week

      With over 1,000 companies reporting, these are some of the best earnings charts to start the week.

        Will S.E.T. Arm Drive Zimmer Biomet's (ZBH) Q3 Earnings?

        Zimmer Biomet (ZBH) poised to gain on strength in S.E.T as well as Spine & CMF segments in Q3.

          Is Zimmer Biomet (ZBH) a Great Stock for Value Investors?

          Is Zimmer Biomet (ZBH) a great pick from the value investor's perspective right now? Read on to know more.

            Zimmer Biomet (ZBH) Launches Persona Partial Knee System

            Zimmer Biomet (ZBH) is constantly trying to turn its Knees business around. Keeping in line with the efforts, the company has launched Persona Partial Knee System.

              New Strong Sell Stocks for September 6th

              Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

                Zimmer (ZBH) Plagued by Various Internal and External Issues

                Zimmer Biomet (ZBH) continues to suffer a bad patch, entangled with issues including its decade-old CEO's recent exit post a dull earnings season due to poor knee business.

                  New Strong Sell Stocks for August 14th

                  Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

                    Zimmer (ZBH) Tops Q2 Earnings, Drops View on Dull Sales

                    Zimmer Biomet's (ZBH) Q2 earnings results disappoint with an unimpressive Knee, Hip and Dental performances.

                      Zimmer Biomet (ZBH) Misses Q2 Earnings, Meets Sales Estimate

                      Zimmer Biomet's (ZBH) Knees and Hips segment decreases year over year.

                        Zimmer Biomet's Preliminary Q2 Numbers Solid, CEO Steps Down

                        Indiana-based Zimmer Biomet Holdings, Inc. (ZBH), a leading player in the global musculoskeletal space, recently announced second-quarter 2017 preliminary results.

                          Zimmer Biomet (ZBH) Launches X-Ray-Based X-PSI Knee System

                          Zimmer Biomet Holdings, Inc. (ZBH) recently launched a X-ray-based Patient Specific Instrument, X-PSI Knee System.

                            FDA Passes Zimmer Biomet's (ZBH) Zhejiang Facility Issue

                            Zimmer Biomet Holdings, Inc. (ZBH) revealed that the U.S. Food and Drug Administration (FDA) has closed out its 'Warning Letter' related to the company's Zhejiang, China manufacturing facility.

                              Zimmer Biomet Rides on Spine Business, Knee Challenges Stay

                              On Jun 6, we issued an updated research report on Warsaw, IN-based Zimmer Biomet Holdings Inc. (ZBH).

                                Zimmer Biomet (ZBH) Beats on Q1 Earnings and Sales Estimates

                                Zimmer Biomet has a Zacks Rank #3 (Hold) but that could change following its first quarter 2017 earnings report which has just released.

                                  Should You Buy Zimmer Biomet (ZBH) Ahead of Earnings?

                                  Zimmer Biomet (ZBH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

                                    Medical Product Stocks' Earnings on Apr 27: ZBH, RMD & More

                                    Let's take a look at the major Medical products stocks slated to release their Jan-Mar 2017 quarter's reports on Apr 27.

                                      Will Zimmer Biomet (ZBH) Beat Earnings Estimates in Q1?

                                      Zimmer Biomet Holdings, Inc. (ZBH) is expected to beat earnings when it reports its first-quarter 2017 financial numbers on Apr 27.

                                        Is Zimmer Biomet (ZBH) a Great Stock for Value Investors?

                                        Let's see if Zimmer Biomet Holdings, Inc. (ZBH) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.

                                          MedTech Long-Term Prospects Impress: Which Stocks to Buy?

                                          President Trump will finally replace the ACA and implement his own strategy, the nation is clearly divided into "we need" and "don't need" camps.

                                            Zimmer Biomet (ZBH): Tops Q4 Earnings Estimates, Meets Sales

                                            Zimmer Biomet (ZBH) has posted mixed results with its earnings surpassing the Zacks Consensus Estimate and revenues in line with the mark.

                                              Medical Products Stocks' Earnings on Jan 31: ZBH, TMO, ABC

                                              Let's take a look at the major Medical Product stocks slated to release their earnings results on tomorrow.

                                                Zimmer Biomet (ZBH) Q4 Earnings: A Surprise in the Cards?

                                                Zimmer Biomet Holdings, Inc. (ZBH) is expected to report fourth-quarter 2017 financial numbers on Jan 31, before the opening bell.

                                                  Does Zimmer Biomet Make for a Suitable Value Investment?

                                                  The solid Key Value Statistics are likely to make Zimmer Biomet (ZBH) a decent pick for the value investors.